Compare XLO & NSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XLO | NSAI |
|---|---|---|
| Founded | 2016 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 47.9M |
| IPO Year | 2021 | 2026 |
| Metric | XLO | NSAI |
|---|---|---|
| Price | $8.45 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 13.5K | ★ 40.7K |
| Earning Date | 11-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | N/A |
| Revenue This Year | $3.55 | N/A |
| Revenue Next Year | $9.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $9.82 |
| 52 Week High | $22.60 | $10.00 |
| Indicator | XLO | NSAI |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 70.27 |
| Support Level | $7.29 | $9.82 |
| Resistance Level | $9.35 | N/A |
| Average True Range (ATR) | 0.67 | 0.02 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 58.97 | 100.00 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
NorthStrive Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.